|
||||||||||||||||||||||
|
||||||||||||||||||||||
Related Issue Limit Info
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Capital Market Instrument To Be Issued Info
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Redemption Plan of Capital Market Instrument Sold | ||||||||||||||||||||||
|
||||||||||||||||||||||
Additional Explanations
|
||||||||||||||||||||||
The sale of a debt instrument to non-resident investors that approved by the Capital Markets Board on March 18, 2021, and quoted on the Euronext Dublin Stock Exchange, was completed on May 27, 2021. The amounts related to a debt instrument issued & sold abroad with a nominal value of Euro 350 million, maturity of 5 years, redemption date May 27, 2026, priced at 3.00% repayment yield and coupon rate has been determined as 3.00%, transferred to our Company's accounts. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||||||||||||||||
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.